Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew G Bushmakin

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Journal of Patient-Reported Outcomes|September 22, 2022
Functional Assessment of Chronic Illness Therapy-Fatigue is a reliable and valid measure in patients with active ankylosing spondylitisDavid Cella, William R Lenderking, Peter Chongpinitchai, et al.
Annals of Hematology|April 21, 2020
Relationship between molecular response and quality of life with bosutinib or imatinib for chronic myeloid leukemiaTim H Brümmendorf, Carlo Gambacorti-Passerini, Andrew G Bushmakin, et al.
Health and Quality of Life Outcomes|March 29, 2011
Relationships between changes in pain severity and other patient-reported outcomes: an analysis in patients with posttraumatic peripheral neuropathic painRobert van Seventer, Michael Serpell, Flemming W Bach, et al.
Journal of Patient-Reported Outcomes|May 22, 2019
Content validity and psychometric evaluation of Functional Assessment of Chronic Illness Therapy-Fatigue in patients with psoriatic arthritisDavid Cella, Hilary Wilson, Huda Shalhoub, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 4, 2018
Important Group Differences on the Functional Assessment of Cancer Therapy-Kidney Symptom Index Disease-Related Symptoms in Patients with Metastatic Renal Cell CarcinomaDavid Cella, Robert J Motzer, Brian I Rini, et al.
Journal of Patient-Reported Outcomes|May 30, 2019
Retraction Note to: Content validity and psychometric evaluation of functional assessment of chronic illness therapy-fatigue in patients with psoriatic arthritisDavid Cella, Hilary Wilson, Huda Shalhoub, et al.
Journal of Women'S Health (2002)|November 12, 2013
Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trialsJoann V Pinkerton, Lucy Abraham, Andrew G Bushmakin, et al.
Plos One|December 31, 2013
Patterns of anti-osteoporosis medication use among women at high risk of fracture: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)Stephen Gehlbach, Frederick H Hooven, Allison Wyman, et al.
Sleep Medicine|May 5, 2009
The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndromeI Jon Russell, Leslie J Crofford, Teresa Leon, et al.
The Journal of Rheumatology|March 2, 2022
WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or KneePhilip G Conaghan, Robert H Dworkin, Thomas J Schnitzer, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Journal of Patient-Reported Outcomes|September 22, 2022
Functional Assessment of Chronic Illness Therapy-Fatigue is a reliable and valid measure in patients with active ankylosing spondylitisDavid Cella, William R Lenderking, Peter Chongpinitchai, et al.
Annals of Hematology|April 21, 2020
Relationship between molecular response and quality of life with bosutinib or imatinib for chronic myeloid leukemiaTim H Brümmendorf, Carlo Gambacorti-Passerini, Andrew G Bushmakin, et al.
Health and Quality of Life Outcomes|March 29, 2011
Relationships between changes in pain severity and other patient-reported outcomes: an analysis in patients with posttraumatic peripheral neuropathic painRobert van Seventer, Michael Serpell, Flemming W Bach, et al.
Journal of Patient-Reported Outcomes|May 22, 2019
Content validity and psychometric evaluation of Functional Assessment of Chronic Illness Therapy-Fatigue in patients with psoriatic arthritisDavid Cella, Hilary Wilson, Huda Shalhoub, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 4, 2018
Important Group Differences on the Functional Assessment of Cancer Therapy-Kidney Symptom Index Disease-Related Symptoms in Patients with Metastatic Renal Cell CarcinomaDavid Cella, Robert J Motzer, Brian I Rini, et al.
Journal of Patient-Reported Outcomes|May 30, 2019
Retraction Note to: Content validity and psychometric evaluation of functional assessment of chronic illness therapy-fatigue in patients with psoriatic arthritisDavid Cella, Hilary Wilson, Huda Shalhoub, et al.
Journal of Women'S Health (2002)|November 12, 2013
Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trialsJoann V Pinkerton, Lucy Abraham, Andrew G Bushmakin, et al.
Plos One|December 31, 2013
Patterns of anti-osteoporosis medication use among women at high risk of fracture: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)Stephen Gehlbach, Frederick H Hooven, Allison Wyman, et al.
Sleep Medicine|May 5, 2009
The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndromeI Jon Russell, Leslie J Crofford, Teresa Leon, et al.
The Journal of Rheumatology|March 2, 2022
WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or KneePhilip G Conaghan, Robert H Dworkin, Thomas J Schnitzer, et al.
Pageof 11